253169662	253169662	CD	B-NP	O
|	|	NN	I-NP	O
DRMHC	DRMHC	NN	I-NP	O
|	|	NN	I-NP	O
87316871	87316871	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
267967	267967	CD	B-NP	O
|	|	CC	I-NP	O
4/23/1991	4/23/1991	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/5/1991	2/5/1991	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/8/1991	4/8/1991	CD	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
STATUS	STATUS	NN	B-NP	O
POST	POST	NN	I-NP	O
CARDIAC	CARDIAC	NN	I-NP	O
TRANSPLANT	TRANSPLANT	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
ORAL	ORAL	JJ	B-NP	O
HERPES	HERPES	NNS	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
60	60	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
longstanding	longstanding	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
non-ischemic	non-ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
originally	originally	RB	I-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
30	30	CD	B-NP	O
of	of	IN	B-PP	O
March	March	NNP	B-NP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
fatigue	fatigue	NN	B-NP	O
and	and	CC	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
for	for	IN	B-PP	O
augmentation	augmentation	NN	B-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
well	well	RB	B-ADVP	O
until	until	IN	B-PP	O
l96l	l96l	NN	B-NP	B-protein
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
initially	initially	RB	B-ADVP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
bundle-branch	bundle-branch	NN	I-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
transient	transient	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
then	then	RB	B-ADVP	O
had	have	VBD	B-VP	O
high	high	JJ	B-NP	O
grade	grade	NN	I-NP	O
ventricular	ventricular	JJ	I-NP	O
ectopic	ectopic	JJ	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
l972	l972	NN	B-NP	B-protein
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
Quinaglute	Quinaglute	NNP	B-NP	O
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
from	from	IN	B-PP	O
l972	l972	NN	B-NP	B-protein
to	to	TO	B-PP	O
l988	l988	NN	B-NP	B-protein
,	,	,	O	O
examination	examination	NN	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
left	left	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
l988	l988	NN	B-NP	B-protein
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
recurrent	recurrent	JJ	B-NP	O
frequent	frequent	JJ	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
enlarged	enlarged	JJ	I-NP	O
hypokinetic	hypokinetic	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
around	around	IN	B-NP	O
32	32	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
coronary	coronary	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
showed	show	VBD	B-VP	O
acute	acute	JJ	B-NP	O
marginal	marginal	NN	I-NP	O
of	of	IN	B-PP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
and	and	CC	I-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
1/5	1/5	CD	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
by	by	IN	B-PP	O
right	right	JJ	B-NP	O
ventriculogram	ventriculogram	NN	I-NP	O
was	be	VBD	B-VP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
2/8	2/8	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
atypical	atypical	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Subsequent	Subsequent	JJ	B-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
orthopnea	orthopnea	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
,	,	,	O	O
Zaroxolyn	Zaroxolyn	NNP	B-NP	O
,	,	,	O	O
Captopril	Captopril	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Quinaglute	Quinaglute	NNP	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Worthrest	Worthrest	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
symptoms	symptom	NNS	B-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
2.9	2.9	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
Captopril	Captopril	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
ultimately	ultimately	RB	B-VP	O
decided	decide	VBD	I-VP	O
to	to	TO	I-VP	O
treate	treate	VB	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
and	and	CC	I-NP	O
Zaroxolyn	Zaroxolyn	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Cardiac	Cardiac	NNP	I-NP	O
Transplant	Transplant	NNP	I-NP	O
List	List	NNP	I-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
transplant	transplant	NN	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

Exercise	Exercise	NN	B-NP	O
tolerance	tolerance	NN	I-NP	O
test	test	NN	I-NP	O
showed	show	VBD	B-VP	O
8	8	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
43	43	CD	B-NP	O
seconds	second	NNS	I-NP	O
bicycle	bicycle	NN	I-NP	O
with	with	IN	B-PP	O
O2	O2	NN	B-NP	O
uptake	uptake	NN	I-NP	O
of	of	IN	B-PP	O
l2	l2	NN	B-NP	B-protein
.	.	.	O	O

Right	Right	NN	B-NP	O
heart	heart	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
showed	show	VBD	B-VP	O
wedge	wedge	NN	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
.	.	.	O	O

PPD	PPD	NN	B-NP	B-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-NP	O
and	and	CC	I-NP	O
abdominal	abdominal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
showed	show	VBD	B-VP	O
global	global	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
apical	apical	JJ	B-NP	O
thrombus	thrombus	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Cholesterol	Cholesterol	NN	B-NP	O
was	be	VBD	B-VP	O
l53	l53	NN	B-NP	B-protein
,	,	,	O	O
l-2	l-2	NN	B-NP	B-protein
immunoglobulins	immunoglobulin	NNS	I-NP	I-protein
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
toxo	toxo	NN	B-NP	O
was	be	VBD	B-VP	O
plus	plus	CC	O	O
IgG	IgG	NN	B-NP	B-protein
and	and	CC	I-NP	O
minus	minus	NN	I-NP	O
IgM	IgM	NN	I-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
negative	negative	JJ	B-NP	O
hepatitis	hepatitis	NN	I-NP	O
,	,	,	O	O
histo	histo	NN	B-NP	O
,	,	,	O	O
blasto	blasto	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
coccidiomycosis	coccidiomycosis	NN	B-NP	O
.	.	.	O	O

CMV	CMV	NN	B-NP	O
showed	show	VBD	B-VP	O
borderline	borderline	JJ	B-NP	O
IgG	IgG	NN	I-NP	B-protein
and	and	CC	I-NP	O
negative	negative	JJ	I-NP	O
IgM	IgM	NN	I-NP	B-protein
and	and	CC	I-NP	O
EBV	EBV	NN	I-NP	O
showed	show	VBD	B-VP	O
positive	positive	JJ	B-NP	O
IgG	IgG	NN	I-NP	B-protein
and	and	CC	O	O
negative	negative	JJ	B-NP	O
IgM	IgM	NN	I-NP	B-protein
.	.	.	O	O

Since	Since	IN	B-SBAR	O
his	his	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
in	in	IN	B-PP	O
August	August	NNP	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
noted	note	VBN	I-VP	O
worsening	worsen	VBG	I-VP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
and	and	CC	I-VP	O
ended	end	VBN	I-VP	O
up	up	RP	B-PRT	O
being	be	VBG	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Dobutamine	Dobutamine	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
gradually	gradually	RB	I-VP	O
declining	decline	VBG	I-VP	O
course	course	NN	B-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
culminating	culminate	VBG	B-VP	O
in	in	IN	B-PP	O
having	have	VBG	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
transplant	transplant	NN	I-NP	O
when	when	WRB	B-ADVP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
became	become	VBD	B-VP	O
available	available	JJ	B-ADJP	O
.	.	.	O	O

This	This	DT	B-NP	O
occurred	occur	VBD	B-VP	O
on	on	IN	B-PP	O
10/9/9l	10/9/9l	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
post-operative	post-operative	JJ	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
uncomplicated	uncomplicated	JJ	B-ADJP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
subsequent	subsequent	JJ	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
only	only	RB	B-ADVP	O
by	by	IN	B-PP	O
acute	acute	JJ	B-NP	O
worsening	worsening	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
Cyclosporin	Cyclosporin	NN	I-NP	O
levels	level	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Cyclosporin	Cyclosporin	NN	I-NP	O
held	hold	VBN	B-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
allowed	allow	VBD	B-VP	O
to	to	TO	I-VP	O
come	come	VB	I-VP	O
down	down	RP	B-PRT	O
.	.	.	O	O

His	His	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
an	an	DT	B-NP	O
oral	oral	JJ	I-NP	O
herpes	herpes	NN	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
did	do	VBD	B-VP	O
very	very	RB	B-ADVP	O
well	well	RB	I-ADVP	O
post-operatively	post-operatively	RB	B-ADVP	O
.	.	.	O	O

Multiple	Multiple	JJ	B-NP	O
right	right	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
biopsies	biopsy	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
rejection	rejection	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
biopsy	biopsy	NN	B-NP	O
on	on	IN	B-PP	O
11/21	11/21	CD	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
wedge	wedge	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
l8	l8	CD	B-NP	O
,	,	,	O	O
right	right	JJ	B-NP	B-protein
atrial	atrial	JJ	I-NP	I-protein
pressure	pressure	NN	I-NP	I-protein
l3	l3	NN	I-NP	I-protein
,	,	,	O	O
right	right	JJ	B-NP	B-protein
ventricular	ventricular	JJ	I-NP	I-protein
48/l4	48/l4	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
PA	PA	NN	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
48/24	48/24	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
slow	slow	JJ	B-NP	O
taper	taper	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
steroids	steroid	NNS	I-NP	O
without	without	IN	B-PP	O
event	event	NN	B-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
tremor	tremor	NN	I-NP	O
also	also	RB	B-ADVP	O
post-operatively	post-operatively	RB	B-ADVP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
Cyclosporin	Cyclosporin	NN	B-NP	O
toxicity	toxicity	NN	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
post-operative	post-operative	JJ	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
uncomplicated	uncomplicated	JJ	B-ADJP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
on	on	IN	B-PP	O
1/13/9l	1/13/9l	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
follow-up	follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Blay	Blay	NNP	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Dr.	Dr.	NNP	B-NP	O
Hori	Hori	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Persantine	Persantine	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Clotrimazole	Clotrimazole	NN	B-NP	O
Troche	Troche	NNP	B-NP	O
one	one	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NNP	I-NP	O
,	,	,	O	O
Bactrim	Bactrim	NNP	B-NP	O
DS	DS	NNP	I-NP	O
one	one	CD	B-NP	O
p.o.	p.o.	NN	I-NP	O
q.o.d.	q.o.d.	NNP	B-NP	O
,	,	,	O	O
Procardia	Procardia	NNP	B-NP	O
XL	XL	NNP	I-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Cyclosporin	Cyclosporin	NN	B-NP	O
l50	l50	NN	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Carafate	Carafate	NNP	B-NP	O
one	one	CD	I-NP	O
gram	gram	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
Prednisone	Prednisone	NN	B-NP	O
taper	taper	NN	I-NP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
Transplant	Transplant	NNP	I-NP	O
Team	Team	NNP	I-NP	O
,	,	,	O	O
Imuran	Imuran	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Restoril	Restoril	NNP	B-NP	O
l5	l5	CD	I-NP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Acyclovir	Acyclovir	NN	B-NP	O
Ointment	Ointment	NN	I-NP	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	B-VP	O
lip	lip	VB	I-VP	O
six	six	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Good	Good	NNP	B-NP	O
.	.	.	O	O

SK821/3095	SK821/3095	NN	B-NP	O
DAMION	DAMION	NNP	I-NP	O
GLUMAC	GLUMAC	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
VU9	VU9	NNP	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
3/24/91	3/24/91	CD	B-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
1828	1828	CD	B-NP	O
Report	Report	NNP	I-NP	O
:	:	:	O	O
I5425W0	I5425W0	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
11/19/91	11/19/91	CD	B-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
GILBERTO	GILBERTO	NNP	B-NP	O
H.	H.	NNP	I-NP	O
ME	ME	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SQ57	SQ57	.	O	B-DNA

